A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss

PHASE2CompletedINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

Not specified

Study Completion Date

December 31, 2002

Conditions
HIV InfectionsHIV Wasting Syndrome
Interventions
DRUG

Testosterone enanthate

DRUG

Megestrol acetate

Trial Locations (21)

10003

Beth Israel Med. Ctr. (Mt. Sinai), New York

10021

Cornell University A2201, New York

Memorial Sloan-Kettering Cancer Ctr., New York

19104

Hosp. of the Univ. of Pennsylvania CRS, Philadelphia

20060

Howard University Hosp., Div. of Infectious Diseases, ACTU, Washington D.C.

21287

Johns Hopkins Adult AIDS CRS, Baltimore

27710

Duke Univ. Med. Ctr. Adult CRS, Durham

46202

Indiana Univ. School of Medicine, Infectious Disease Research Clinic, Indianapolis

Indiana Univ. School of Medicine, Wishard Memorial, Indianapolis

60611

Northwestern University CRS, Chicago

70112

Tulane Med. Ctr. - Charity Hosp. of New Orleans, ACTU, New Orleans

80045

University of Colorado Hospital CRS, Aurora

90033

USC CRS, Los Angeles

90035

UCLA CARE Center CRS, Los Angeles

94110

Ucsf Aids Crs, San Francisco

96813

Queens Med. Ctr., Honolulu

96816

Univ. of Hawaii at Manoa, Leahi Hosp., Honolulu

02215

Beth Israel Deaconess Med. Ctr., ACTG CRS, Boston

Unknown

St. Louis ConnectCare, Infectious Diseases Clinic, St Louis

Washington U CRS, St Louis

Univ. of Cincinnati CRS, Cincinnati

All Listed Sponsors
lead

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

NCT00001079 - A Study of Megestrol Acetate Alone or in Combination With Testosterone Enanthate Drug in the Treatment of HIV-Associated Weight Loss | Biotech Hunter | Biotech Hunter